Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Palatin Technologies Inc (PTN)

Palatin Technologies Inc (PTN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,623
  • Shares Outstanding, K 1,703
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,310 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.49
  • Price/Sales 1.99
  • Price/Cash Flow N/A
  • Price/Book 67.59

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.25 +240.28%
on 11/12/25
29.98 -17.71%
on 12/11/25
+13.63 (+123.46%)
since 11/11/25
3-Month
5.61 +339.75%
on 10/27/25
29.98 -17.71%
on 12/11/25
+16.08 (+187.26%)
since 09/11/25
52-Week
1.75 +1,309.71%
on 05/08/25
72.50 -65.97%
on 01/06/25
-19.89 (-44.64%)
since 12/11/24

Most Recent Stories

More News
Palatin Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Significant progress on multiple fronts – obesity pipeline advancing towards the clinic, out-licensing collaboration, strengthened balance sheet, and reinstatement of NYSE American trading

PTN : 24.67 (-3.71%)
Palatin Technologies Announces Closing of Upsized $18.2 Million Public Offering with the Full Exercise of the Underwriters' Over-Allotment Option

Trading of Palatin's common shares resumed trading on NYSE today, November 12, 2025, under the symbol "PTN"

PTN : 24.67 (-3.71%)
Palatin Presents Data at ObesityWeek® 2025 Highlighting Promise of Melanocortin-Based Therapies for Obesity

PRINCETON, N.J. , Nov. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity...

PTN : 24.67 (-3.71%)
PTNT : 8.5300 (-15.12%)
Palatin Announces 1-for-50 Reverse Stock Split

PRINCETON, N.J. , Aug. 8, 2025 /PRNewswire/ -- Palatin Technologies, Inc. (OTCQB: PTNT), today announced a reverse stock split ("Reverse Stock Split") of its shares at a ratio of 1-for-50....

PTN : 24.67 (-3.71%)
PTNT : 8.5300 (-15.12%)
Why This French Biotech Stock Just Soared 586% in One Day

Shares of Abivax SA (NASDAQ: ABVX) went parabolic on Wednesday, skyrocketing 586% to close at $68.60 after the French biotech firm announced overwhelmingly positive Phase 3 data for its lead drug candidate,...

NDAQ : 93.85 (+2.10%)
PTN : 24.67 (-3.71%)
ABVX : 133.09 (+4.36%)
PTNT : 8.5300 (-15.12%)
Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRX

Positive expectations from key clinical trials, delisting fears and some regulatory changes triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11, 2025.

SMMT : 17.99 (+0.28%)
RXRX : 4.58 (-3.98%)
PTN : 24.67 (-3.71%)
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:RYTM),(NASDAQ:VKTX),(NASDAQ:GPCR),(NYSE:NVO) EQNX::TICKER_END

VKTX : 37.21 (-0.85%)
RYTM : 117.62 (+12.26%)
NVO : 50.29 (+2.53%)
GPCR : 67.44 (-2.18%)
PTN : 24.67 (-3.71%)
Melanocortin Receptor R&D to Target Increasing Prevalence of Obesity-Related Disorders

/PRNewswire/ -- The Melanocortin Receptor 4 (MC4R) is a protein-coupled receptor primarily expressed in the central nervous system, playing a pivotal role in...

VKTX : 37.21 (-0.85%)
RYTM : 117.62 (+12.26%)
NVO : 50.29 (+2.53%)
GPCR : 67.44 (-2.18%)
PTN : 24.67 (-3.71%)
Palatin Announces Preliminary Quarter Ended September 30, 2023 Vyleesi® Product Revenue Results

/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...

PTN : 24.67 (-3.71%)
Palatin Announces Positive Preclinical Data Showing Synergistic Weight Loss; Initiating Clinical Study of Melanocortin 4 Receptor Agonist + GLP-1 in Obese Patients

/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...

PTN : 24.67 (-3.71%)

Business Summary

Palatin Technologies, Inc is a development-stage medical technology companyinvolved in developing and commercializing products and technologies fordiagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling...

See More

Key Turning Points

3rd Resistance Point 36.52
2nd Resistance Point 33.25
1st Resistance Point 28.96
Last Price 24.67
1st Support Level 21.40
2nd Support Level 18.13
3rd Support Level 13.84

See More

52-Week High 72.50
Fibonacci 61.8% 45.47
Fibonacci 50% 37.13
Fibonacci 38.2% 28.78
Last Price 24.67
52-Week Low 1.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar